EPISODE · Aug 14, 2024 · 5 MIN
Weekly Headlines: Aldeyra Reports New Phase 3 Data for DED Drug Candidate Reproxalap
from Eyewire News: The Podcast · host Eyewire News
Aldeyra Reports New Phase 3 Data for DED Drug Candidate Reproxalap • Lensar Receives European Approval for ALLY System • Lenz Therapeutics Submits NDA for Presbyopia Eye Drop Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Weekly Headlines: Aldeyra Reports New Phase 3 Data for DED Drug Candidate Reproxalap
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m